Prevalence of hepatitis B infection among voluntary donor in Wuse District Hospital, Abuja
DOI:
https://doi.org/10.30574/gscbps.2021.14.1.0017Keywords:
Prevalence, Hepatitis B, Blood Donor, Transfusion, ScreeningAbstract
Blood transfusion is an important and lifesaving intervention of the healthcare system there by reducing mortality worldwide, resulting from high level of blood demanding health conditions. Screening and testing of the donated blood are necessary in order to prevent the risks and complications associated with blood transfusion. This study was carried out in retrospective, considering the six (6) month testing and screening of seven hundred and fifty (n= 750) samples from the relative donor of Wuse District Hospital, Abuja, this was done using the screening method with the use of a rapid test kit. The gender showed 689(91.9%) for male and female 61(8.1), result showed that 32(4.3%) were positive with 28(87.5%) male and 4(12.5%) female respectively, the percentage age group showed the highest to be (56.4%)of 29 -38 years. The study showed an overall seroprevalence of (4.3%) falling within (2 – 7%) intermediate risk group for hepatitis B virus infection as described by the WHO. Government should make available the vaccine against HBV, create more awareness for vaccination and make it free for all (without payment) as soon as possible
Metrics
References
Drosten C, Nippraschk T, Manegold C, Meisel H, Brixner V, Roth WK, Apedjinou A, Gunther S. Prevalence of hepatitis B virus DNA in anti-HBC-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus.JClinVirol. 2004; 29: 59-68.
Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B infection in Nigeria, 2000-2013: A systematic review and meta-analysis. Nig.J.clinical practice.
Hepatitis B, General information, US Dept of Health and Human Services. 2016.
Mary N, Bhupinder A. Hepatitis B (HBV,Hep B). 2017.
Colin WS, Edgan PS, Lyn F, Anthony EF, Beth PB. Hepatitis B virus infection; Epidiomology and vaccination. 2006; 8(112-125).
World Health Organization Global Report. 2017.
Lavanya V, ViswanathanT, SheebaMS, Malavizhi A, Moorthy K. Prevalence of Hepatitis B among donors with antibodies to HBcAg. 2012.
Sirisena ND, Njoku MO, Idoko JA. Carriage rate of hepatitis B surface antigen in urban community in Jos. Nig Postgrad J. 2002; 9: 7-10.
Ott J, Stevens GA, Groeger J, Wiersma ST. Global Epidiomology of Hepatitis B virus infection: New estimates of age-specific HBsAgsero –prevalence and endemicity. Vaccine. 2012; 30: 221-9.
Forbi J, Pennap G, Silas-Ndukuba C, Agabi Y, Agwale S. Serological maker and risk factors for hepatitis B virius among students in a Nigerian university. East AfrJ Public Health. 2009; 6: 152-5.
Ola SO, Otegbayo JO, Odaibo GN, Olaley OD, Olubuyide ON. Serum hepatitis C and hepatitis B surface antienaemiia in Nigeria patients with acute icteric hepatitis. West Afr J Med. 2002; 21: 215-7.
Bada AS, Olatuni PO, Adewuyi JO, IseniyiJO, Onile BA. Hepatitis B surface antienaemia in Ilorin, Kwara State, Nigeria. Cent Afr J Med. 1996; 42: 139-41.
Belo AC. Prevalence of hepatitis B marers in surgeons in Lagos, Nigeria. East Afr Med J. 2000; 77: 283-5.
Sadoh AE, Sadoh WE. Serological marker of hepatitis B infection in infants presenting for theirfirst immunization. 2016 Nig. J paeadiatr. 2013; 40: 248-53.
Finlayson ND, Hayes PC, Simpson KJ. Diseases of Liver and biliary system. In, Christopher H., John A. A., Hunter N. A. et al (eds) Davidson's Principle and Practice of Medicine. Edinburg, Churchill Livingstone, 18'h edition. 1999; 683-736.
Surendra K, Prakash G, Bishnu RT, ManitaR. (2008). HBsAgSerosurveillance among Nepalese blood donors. Ann. Trop. Med. Public Health. 2008; 1(1): 15-18.
Chukwuka JO, Ezechukwu CC, Egbuonu I, Okoli CC. Prevalence of Hepatitis B Surface Antigen in Primary School Children in Nnewi Nigeria. Nig J Paed. 2003; 7: 8-10.
Angyo IA, Yakubu AM. Lack of association between some risk factors and Hepatitis B Surface Antigenaemia in children with sickle cell anaemia. W Afr Med J 2001; 20: 214-8.
Abiaya MO, Ebohom PA. Blood transfusion hazards in Benin City, Nigeria. Nig Med J. 1992; 12: 251-4.
Multimer DJ, Olomi A, Skidmore S, Olomu N, Ratcliffe D, Rodger S. Viral hepatitis in Nigeria-sickle cell disease and commercial blood donors. QJM. 1994; 87: 407-11.
Sear M. The Jaundiced Child. In: a Manual of Tropical Paediatrics. Cambridge University press. 2000; 185-200.
United Nations System in Nigeria Report. 2001.
Hepatitis B Fact Sheet M204, World Health int. July 2014. Archived from original on 9th November. 2014.
Yuen, MF, et al. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis. 2011; 52: 624–632.
Dhawan HK, Marwaha N, Sharma RR, Chawla Y, Thakral B, Saluja K, Sharma SK, Thakur MK, Jain A. (2008). Anti-HBc screening in Indian blood donors: Still an unresolved issue. World J. Gastroenterol. 2008; 14(34): 5327-5330.
WHO Global Database on blood Safety: summary report. 2012.
Khan ZT, Asim S, Tariz Z, Ehsan IA, Malik RA, Ashfaq. Prevalence of Transfusion transmitted infections in healthy blood donors in Rawalpindi District, Pakistan–a five-year study. Int. J. Pathol. 2007; 5: 21-25.
Tsoi WC, Lelie N, Lin CK. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay. Transfusion. 2013; 53: 2477–2488.
Chao Liu et al. prevalence of HBV DNA among seronegative blood donors in China. 2015.
Stramer SL, et al. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med. 2011; 364: 236–247.
Su, TH, et al. The clinical significance of occult hepatitis B transfusion in Taiwan–a look-back study. Transfus Med. 2011; 21: 33–41.
Kumar CH, Lt Col Gupta PK, Jaiprakash M. The role of anti-HBc IgM in screening of blood donors.MJAFI. 2007; 63: 350-352.
Tong S, Brook GF. Hepatitis Viruses. In, Butel J. S., Muse S. A. (eds) edical Microbiology.
Emechebe GO, Emordi IJ, Ikefuna AN. Ilechukwu GC, Igwu WC, Ejiofor OS. Hepatitis B infection in Nigeria. A Review. 2009; 0(1): 18.
Mel Krajden. The Laboratory diagnosis of hepatitis B virus. Cand J Infect dis Med Microbiol. 2015; 16(2): 65-72.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
